The CROM-VAS Test: A novel and reliable clinical test to assess immediate pain relief following treatment for movement-evoked neck pain

IF 2.2 3区医学 Q1 REHABILITATION

Musculoskeletal Science and Practice Pub Date : 2024-09-21 DOI:10.1016/j.msksp.2024.103191

{"title":"The CROM-VAS Test: A novel and reliable clinical test to assess immediate pain relief following treatment for movement-evoked neck pain","authors":"","doi":"10.1016/j.msksp.2024.103191","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The CROM-VAS Test is a novel method to quantify immediate hypoalgesic treatment effects for neck pain by measuring the reduction in pain intensity (using a VAS) at the same (sub)maximal neck position (using a CROM device) before and after treatment. It is a novel test designed to quantify immediate pain relief following treatment, without the potentially confounding effects of simultaneous improvements in function.</div></div><div><h3>Objectives</h3><div>(1) To describe the CROM-VAS Test, (2) To assess reliability and absolute agreement of the CROM-VAS Test, and (3) To evaluate its distinctiveness by comparing it to changes in pressure pain threshold (PPT) and baseline pain scores.</div></div><div><h3>Design</h3><div>Cross-sectional study.</div></div><div><h3>Methods</h3><div>The CROM-VAS Test was assessed in 58 people with non-specific neck pain treated with cervical mobilisation and cervicothoracic manipulation. Inter-rater reliability (intraclass correlation coefficient (ICC<sub>1.1</sub>)) and absolute agreement (standard error of measurement (SEM), minimal detectable change (MDC) and Bland-Altman limits of agreement (LoA)) were determined.</div></div><div><h3>Results</h3><div>Reliability was high (ICC<sub>1.1</sub>: 0.91 (95%CI: 0.85–0.95) for the CROM-VAS Test in the painful direction and 0.73 (95%CI: 0.54–0.85) in the non/least painful direction). Agreement was good (CROM-VAS Test (painful direction): SEM: 2.3 mm; MDC: 6.4 mm; LoA: 13.5 to 16.6 mm; CROM-VAS Test (non/least painful direction): SEM: 4.0 mm; MDC: 11.1 mm; LoA: 14.7 to 22.0 mm). Low or negative correlations were observed between CROM-VAS Test scores and changes in PPT and baseline neck pain scores.</div></div><div><h3>Conclusion</h3><div>The CROM-VAS Test has good clinimetric properties. It measures a distinct dimension of pain relief compared to PPTs and baseline pain scores.</div></div>","PeriodicalId":56036,"journal":{"name":"Musculoskeletal Science and Practice","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468781224002868/pdfft?md5=2382e791b5a2d03a9223df362822b2d9&pid=1-s2.0-S2468781224002868-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Musculoskeletal Science and Practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468781224002868","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"REHABILITATION","Score":null,"Total":0}

引用次数: 0

Abstract

Background

The CROM-VAS Test is a novel method to quantify immediate hypoalgesic treatment effects for neck pain by measuring the reduction in pain intensity (using a VAS) at the same (sub)maximal neck position (using a CROM device) before and after treatment. It is a novel test designed to quantify immediate pain relief following treatment, without the potentially confounding effects of simultaneous improvements in function.

Objectives

(1) To describe the CROM-VAS Test, (2) To assess reliability and absolute agreement of the CROM-VAS Test, and (3) To evaluate its distinctiveness by comparing it to changes in pressure pain threshold (PPT) and baseline pain scores.

Design

Cross-sectional study.

Methods

The CROM-VAS Test was assessed in 58 people with non-specific neck pain treated with cervical mobilisation and cervicothoracic manipulation. Inter-rater reliability (intraclass correlation coefficient (ICC_1.1)) and absolute agreement (standard error of measurement (SEM), minimal detectable change (MDC) and Bland-Altman limits of agreement (LoA)) were determined.

Results

Reliability was high (ICC_1.1: 0.91 (95%CI: 0.85–0.95) for the CROM-VAS Test in the painful direction and 0.73 (95%CI: 0.54–0.85) in the non/least painful direction). Agreement was good (CROM-VAS Test (painful direction): SEM: 2.3 mm; MDC: 6.4 mm; LoA: 13.5 to 16.6 mm; CROM-VAS Test (non/least painful direction): SEM: 4.0 mm; MDC: 11.1 mm; LoA: 14.7 to 22.0 mm). Low or negative correlations were observed between CROM-VAS Test scores and changes in PPT and baseline neck pain scores.

Conclusion

The CROM-VAS Test has good clinimetric properties. It measures a distinct dimension of pain relief compared to PPTs and baseline pain scores.

查看原文本刊更多论文

CROM-VAS 测试：一种新颖可靠的临床测试，用于评估运动诱发的颈部疼痛治疗后的即时疼痛缓解情况

背景CROM-VAS测试是一种新型方法，通过测量治疗前后相同（亚）最大颈部位置（使用CROM设备）的疼痛强度降低情况（使用VAS）来量化颈部疼痛的即时低痛治疗效果。目的（1）描述 CROM-VAS 测试；（2）评估 CROM-VAS 测试的可靠性和绝对一致性；（3）通过与压力痛阈值（PPT）和基线疼痛评分的变化进行比较，评估 CROM-VAS 测试的独特性。方法对 58 名接受颈椎活动和颈胸手法治疗的非特异性颈痛患者进行 CROM-VAS 测试评估。结果可靠性高（CROM-VAS 测试在疼痛方向上的 ICC1.1：0.91（95%CI：0.85-0.95），在非/轻度疼痛方向上的 ICC1.1：0.73（95%CI：0.54-0.85））。一致性良好（CROM-VAS 测试（疼痛方向）：SEM：2.3 毫米；MDC：6.4 毫米；LoA：13.5 至 16.6 毫米：13.5至16.6毫米；CROM-VAS测试（非/最轻疼痛方向）：SEM: 4.0 mm; MDC: 11.1 mm; LoA：14.7至22.0毫米）。CROM-VAS测试评分与PPT的变化和基线颈痛评分之间的相关性较低或呈负相关。结论 CROM-VAS 测试具有良好的临床测量特性，与 PPT 和基线疼痛评分相比，它能测量出疼痛缓解的不同维度。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Musculoskeletal Science and Practice Health Professions-Physical Therapy, Sports Therapy and Rehabilitation

CiteScore

4.10

自引率

8.70%

发文量

152

审稿时长

48 days

期刊介绍： Musculoskeletal Science & Practice, international journal of musculoskeletal physiotherapy, is a peer-reviewed international journal (previously Manual Therapy), publishing high quality original research, review and Masterclass articles that contribute to improving the clinical understanding of appropriate care processes for musculoskeletal disorders. The journal publishes articles that influence or add to the body of evidence on diagnostic and therapeutic processes, patient centered care, guidelines for musculoskeletal therapeutics and theoretical models that support developments in assessment, diagnosis, clinical reasoning and interventions.